Beatriz M. Luchiari
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model.
Journal: Health economics review
Published: January 20, 2023
Very low HDL levels: clinical assessment and management.
Journal: Archives of endocrinology and metabolism
Published: January 18, 2023
Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial.
Journal: Cardiovascular diabetology
Published: June 29, 2022
Rationale and design of the Brazilian diabetes study: a prospective cohort of type 2 diabetes.
Journal: Current medical research and opinion
Published: February 17, 2022
Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis.
Journal: Frontiers in cardiovascular medicine
Published: February 15, 2022
Compliance with Cardiovascular Prevention Guidelines in Type 2 Diabetes Individuals in a Middle-Income Region: A Cross-Sectional Analysis.
Journal: Diagnostics (Basel, Switzerland)
Published: February 07, 2022
The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus.
Journal: Metabolites
Published: November 08, 2021
Glucose-lowering Drugs and Hospitalization for Heart Failure: A Systematic Review and Additive-effects Network Meta-analysis With More Than 500 000 Patient-years.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 03, 2021
Cardiovascular safety of naltrexone and bupropion therapy: Systematic review and meta-analyses.
Journal: Obesity reviews : an official journal of the International Association for the Study of Obesity
Published: December 29, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026